$5.92 Billion is the total value of Eventide Asset Management's 139 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 29.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $194,022,823 | +249.6% | 6,877,803 | +113.1% | 3.28% | +222.1% |
| EXAS | Buy | EXACT SCIENCES CORP | $175,378,344 | +38.5% | 1,867,714 | +0.0% | 2.96% | +27.6% |
| ODFL | Buy | OLD DOMINION FREIGHT LINE IN | $164,488,464 | +8.6% | 444,864 | +0.1% | 2.78% | +0.0% |
| TT | Buy | TRANE TECHNOLOGIES PLC | $150,953,103 | +4.0% | 789,256 | +0.1% | 2.55% | -4.2% |
| GH | Buy | GUARDANT HEALTH INC | $143,507,952 | +226.5% | 4,008,602 | +113.8% | 2.42% | +200.9% |
| ARGX | Buy | ARGENX SEsponsored adr | $128,250,789 | +4.7% | 329,076 | +0.0% | 2.17% | -3.6% |
| FLYW | Buy | FLYWIRE CORPORATION | $126,293,255 | +6.9% | 4,068,726 | +1.1% | 2.13% | -1.6% |
| WCN | Buy | WASTE CONNECTIONS INC | $115,690,401 | +2.8% | 809,420 | +0.0% | 1.96% | -5.3% |
| POOL | Buy | POOL CORP | $105,581,794 | +15.0% | 281,822 | +5.1% | 1.78% | +5.9% |
| LOW | Buy | LOWES COS INC | $101,222,613 | +13.0% | 448,483 | +0.1% | 1.71% | +4.1% |
| HUBS | Buy | HUBSPOT INC | $94,929,645 | +24.1% | 178,409 | +0.0% | 1.60% | +14.3% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $89,489,530 | +80.9% | 3,459,201 | +68.0% | 1.51% | +66.7% |
| DHI | Buy | D R HORTON INC | $83,754,968 | +24.6% | 688,265 | +0.0% | 1.42% | +14.8% |
| APTV | Buy | APTIV PLC | $82,523,727 | +2.2% | 808,343 | +12.3% | 1.40% | -5.9% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $79,935,762 | +29.5% | 2,638,144 | +38.6% | 1.35% | +19.2% |
| TTD | Buy | THE TRADE DESK INC | $77,732,586 | +27.1% | 1,006,638 | +0.2% | 1.31% | +17.1% |
| LRCX | Buy | LAM RESEARCH CORP | $75,451,192 | +21.7% | 117,368 | +0.3% | 1.28% | +12.0% |
| LAD | Buy | LITHIA MTRS INC | $74,287,991 | +158.6% | 244,280 | +94.6% | 1.26% | +138.3% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $74,035,340 | +122.2% | 1,927,000 | +33.9% | 1.25% | +104.7% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $73,722,061 | +19.4% | 339,968 | +0.0% | 1.25% | +10.0% |
| DV | Buy | DOUBLEVERIFY HLDGS INC | $73,357,856 | +30.2% | 1,884,837 | +0.9% | 1.24% | +20.0% |
| CRWD | Buy | CROWDSTRIKE HLDGS INCcl a | $73,043,445 | +7.3% | 497,334 | +0.3% | 1.23% | -1.2% |
| DLO | Buy | DLOCAL LTD | $69,563,703 | -3.8% | 5,699,607 | +27.9% | 1.18% | -11.3% |
| SWAV | Buy | SHOCKWAVE MED INC | $69,199,652 | +31.9% | 242,457 | +0.2% | 1.17% | +21.6% |
| XMTR | Buy | XOMETRY INC | $67,578,814 | +55.5% | 3,190,690 | +9.9% | 1.14% | +43.3% |
| SHLS | Buy | SHOALS TECHNOLOGIES GROUP INcl a | $62,787,169 | +26.7% | 2,456,462 | +12.9% | 1.06% | +16.7% |
| TREX | Buy | TREX CO INC | $57,856,634 | +34.7% | 882,499 | +0.0% | 0.98% | +24.1% |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $56,545,713 | -10.4% | 2,631,257 | +0.0% | 0.96% | -17.4% |
| MPWR | Buy | MONOLITHIC PWR SYS INC | $52,591,931 | +8.0% | 97,351 | +0.0% | 0.89% | -0.6% |
| ASML | Buy | ASML HOLDING N V | $50,216,478 | +6.6% | 69,288 | +0.1% | 0.85% | -1.8% |
| DDOG | Buy | DATADOG INC | $48,783,986 | +35.6% | 495,873 | +0.1% | 0.82% | +24.8% |
| SPT | Buy | SPROUT SOCIAL INC | $46,287,125 | -13.1% | 1,002,754 | +14.6% | 0.78% | -20.0% |
| LNG | Buy | CHENIERE ENERGY INC | $45,889,765 | -3.3% | 301,193 | +0.0% | 0.78% | -10.9% |
| COGT | Buy | COGENT BIOSCIENCES INC | $40,739,025 | +45.8% | 3,440,796 | +32.9% | 0.69% | +34.3% |
| Buy | AURA BIOSCIENCES INC | $36,253,660 | +54.7% | 2,935,519 | +16.2% | 0.61% | +42.6% | |
| New | TOAST INCcl a | $36,199,256 | – | 1,603,866 | +100.0% | 0.61% | – | |
| PRTA | Buy | PROTHENA CORP PLC | $30,395,183 | +42.9% | 445,155 | +1.5% | 0.51% | +31.8% |
| WDAY | Buy | WORKDAY INCcl a | $30,204,430 | +6620.6% | 133,713 | +6044.9% | 0.51% | +6275.0% |
| TRGP | Buy | TARGA RES CORP | $29,813,621 | +30.6% | 391,769 | +25.2% | 0.50% | +20.3% |
| KLAC | Buy | KLA CORP | $29,442,654 | +44.2% | 60,704 | +18.7% | 0.50% | +32.8% |
| WMB | Buy | WILLIAMS COS INC | $29,311,757 | +39.3% | 898,307 | +27.5% | 0.50% | +28.2% |
| ORLY | Buy | OREILLY AUTOMOTIVE INC | $29,081,243 | +12.6% | 30,442 | +0.1% | 0.49% | +3.6% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $25,665,333 | +33.9% | 75,058 | +0.0% | 0.43% | +23.3% |
| IMGN | New | IMMUNOGEN INC | $24,531,000 | – | 1,300,000 | +100.0% | 0.42% | – |
| BEPC | Buy | BROOKFIELD RENEWABLE CORPcl a sub vtg | $24,454,824 | -9.8% | 775,851 | +0.1% | 0.41% | -16.9% |
| SHW | Buy | SHERWIN WILLIAMS CO | $24,455,720 | +68.1% | 92,105 | +42.3% | 0.41% | +54.7% |
| Buy | AMYLYX PHARMACEUTICALS INC | $24,090,174 | +79.3% | 1,116,837 | +143.8% | 0.41% | +64.8% | |
| KROS | Buy | KEROS THERAPEUTICS INC | $23,304,400 | +81.9% | 580,000 | +93.3% | 0.39% | +67.7% |
| NOVT | Buy | NOVANTA INC | $23,199,730 | +15.8% | 126,017 | +0.1% | 0.39% | +6.5% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $21,678,000 | +57.1% | 600,000 | +61.7% | 0.37% | +44.7% |
| PNR | Buy | PENTAIR PLC | $21,331,372 | +42.2% | 330,207 | +21.6% | 0.36% | +31.3% |
| New | HASHICORP INC | $19,612,014 | – | 749,122 | +100.0% | 0.33% | – | |
| CMS | Buy | CMS ENERGY CORP | $18,877,197 | +173.3% | 321,314 | +185.5% | 0.32% | +151.2% |
| ALKS | New | ALKERMES PLC | $17,597,893 | – | 562,233 | +100.0% | 0.30% | – |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $15,577,100 | +104.7% | 490,000 | +57.1% | 0.26% | +87.9% |
| FANG | New | DIAMONDBACK ENERGY INC | $14,942,594 | – | 113,753 | +100.0% | 0.25% | – |
| MSCI | New | MSCI INC | $14,273,455 | – | 30,415 | +100.0% | 0.24% | – |
| Buy | GXO LOGISTICS INCORPORATED | $13,830,577 | +24.5% | 220,162 | +0.0% | 0.23% | +14.7% | |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $13,868,800 | +50.8% | 1,970,000 | +78.6% | 0.23% | +38.5% |
| Buy | R1 RCM INC | $13,573,757 | +51.9% | 735,705 | +23.5% | 0.23% | +39.6% | |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $13,257,031 | – | 1,026,086 | +100.0% | 0.22% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $12,157,500 | – | 750,000 | +100.0% | 0.20% | – |
| RPHM | New | RENEO PHARMACEUTICALS INC | $11,480,000 | – | 1,750,000 | +100.0% | 0.19% | – |
| RVMD | New | REVOLUTION MEDICINES INC | $9,646,986 | – | 360,635 | +100.0% | 0.16% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $8,838,400 | – | 320,000 | +100.0% | 0.15% | – |
| EQIX | New | EQUINIX INC | $7,466,245 | – | 9,524 | +100.0% | 0.13% | – |
| TMDX | New | TRANSMEDICS GROUP INC | $5,665,374 | – | 67,461 | +100.0% | 0.10% | – |
| New | XOMETRY INCnote 1.000% 2/0 | $1,588,650 | – | 2,100,000 | +100.0% | 0.03% | – | |
| New | NERDWALLET INC | $1,411,500 | – | 150,000 | +100.0% | 0.02% | – | |
| NOW | Buy | SERVICENOW INC | $509,145 | +52.6% | 906 | +26.2% | 0.01% | +50.0% |
| NVDA | Buy | NVIDIA CORPORATION | $519,892 | +415.6% | 1,229 | +238.6% | 0.01% | +350.0% |
| COMP | New | COMPASS INCcl a | $451,076 | – | 128,879 | +100.0% | 0.01% | – |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $481,838 | +44.5% | 5,108 | +26.7% | 0.01% | +33.3% |
| ALGN | New | ALIGN TECHNOLOGY INC | $416,588 | – | 1,178 | +100.0% | 0.01% | – |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $367,349 | +94.8% | 3,640 | +79.6% | 0.01% | +100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-15
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 40 | Q3 2023 | 3.2% |
| PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
| ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
| VERACYTE INC | 38 | Q3 2023 | 1.5% |
| LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
| MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
| ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
| KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
| Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
| SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.